Teneligliptin 20 MG + Metformin Hydrochloride 500 MG ER Tablets – MELITEN M 20/500

Teneligliptin 20 MG + Metformin Hydrochloride 500 MG ER Tablets – A novel bilayered tablet for comprehensive and sustained control of T2DM.

MELITEN M 20/500 – Teneligliptin 20 mg + Metformin(ER) 500 mg Tablets formulation combines two potent antidiabetic agents:
Teneligliptin: A DPP-4 inhibitor that enhances glucose-dependent insulin secretion and suppresses glucagon release by increasing incretin hormone levels. This helps regulate postprandial glucose levels effectively.
Metformin (Extended Release): A biguanide that primarily reduces hepatic glucose production, improves insulin sensitivity, and enhances peripheral glucose uptake. Its sustained-release formulation ensures a steady release, minimizing gastrointestinal side effects and ensuring better glycemic control throughout the day.
The bilayered design optimizes the release of each component, offering dual-phase action: immediate release for quick onset and sustained release for prolonged efficacy.

Recommended by specialists:
✅General Physician: For metabolic health support and improved glycaemic control
✅Diabetologist: For the treatment of Type 2 Diabetes Mellitus

Key benefits of Teneligliptin 20 MG + Metformin Hydrochloride 500 MG ER – MELITEN M 20/500
✅Bilayered Technology: Provides a synergistic effect with immediate and sustained drug release, improving therapeutic outcomes and patient compliance.
✅Dual Mechanism of Action: Combines Teneligliptin’s incretin-based action with Metformin’s glucose-lowering effects for optimal glycaemic control.
✅Gastrointestinal Tolerance: The sustained-release formulation of Metformin reduces gastrointestinal discomfort, ensuring better patient adherence.

Indications:
✅Type 2 Diabetes Mellitus
✅Improved Glycemic Control
✅ Metabolic Health Support